Denied: FDA rejects Agile's contraception patch for second time
Agile Therapeutics $AGRX is suffering yet another rejection from the FDA this morning as regulators declined to approve its contraception patch for the second time …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.